MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced that the United States Adopted Names (USAN ...

Antitumor activity observed with confirmed partial responses in 50% of patientsat highest dose tested to date, across ...

The partnership underscores Servier’s commitment to developing targeted therapies that address unmet medical needs in oncology Servier will ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announces the publication of preclinical data for ...

The partnership underscores Servier's commitment to developing targeted therapies that address unmet medical needs in oncologyServier will develop and commercialize BDTX-4933, a Phase 1 asset with bes ...

All the latest breaking news on United States. Browse ibtimes archives of photos, videos and articles on United States.

Combining BET inhibitors and PARP inhibitors might help patients resistant to chemotherapy, the study suggests.

If you can’t see this ‘diamond gap’, you could have finger clubbing, which can be a sign of lung cancer. Finger clubbing is seen in 35% of people with non-small cell lung cancer (NSCLC), and ...

Screening adherence is associated with increased overall and early-stage lung cancer detection rates among individuals undergoing lung cancer screening (LCS); however, adherence rates appear to ...

Now, as a scientist at the University of Pennsylvania, Charly is working to rewrite the future of cancer treatment.

A team of researchers from Cleveland Clinic Genomic Medicine share insights from an early set of 19,000 patients to receive ...